4//SEC Filing
ACCELRYS, INC. 4
Accession 0001453727-13-000020
CIK 0001002388operating
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 6:35 PM ET
Size
7.7 KB
Accession
0001453727-13-000020
Insider Transaction Report
Form 4
ACCELRYS, INC.ACCL
HAHN MATHEW A
VP, Research and Development
Transactions
- Sale
Common stock
2013-09-25$9.96/sh−6,772$67,417→ 0 total - Sale
Common stock
2013-09-27$9.95/sh−200$1,990→ 0 total - Sale
Common stock
2013-09-26$9.98/sh−10,903$108,773→ 0 total
Footnotes (1)
- [F1]Pursuant to his 10b5-1 plan, Dr. Hahn disposed of common stock acquired through the sale of Scitegic to Accelrys in 2004.
Documents
Issuer
ACCELRYS, INC.
CIK 0001002388
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001002388
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 6:35 PM ET
- Size
- 7.7 KB